ATE56020T1 - Chemische verbindungen. - Google Patents
Chemische verbindungen.Info
- Publication number
- ATE56020T1 ATE56020T1 AT86304650T AT86304650T ATE56020T1 AT E56020 T1 ATE56020 T1 AT E56020T1 AT 86304650 T AT86304650 T AT 86304650T AT 86304650 T AT86304650 T AT 86304650T AT E56020 T1 ATE56020 T1 AT E56020T1
- Authority
- AT
- Austria
- Prior art keywords
- branched
- straight
- alkyl
- optionally substituted
- different
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Luminescent Compositions (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT21236/85A IT1222367B (it) | 1985-06-21 | 1985-06-21 | Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico |
| EP86304650A EP0207680B1 (de) | 1985-06-21 | 1986-06-17 | Chemische Verbindungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE56020T1 true ATE56020T1 (de) | 1990-09-15 |
Family
ID=11178826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86304650T ATE56020T1 (de) | 1985-06-21 | 1986-06-17 | Chemische verbindungen. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4703054A (de) |
| EP (1) | EP0207680B1 (de) |
| JP (1) | JPH0688979B2 (de) |
| KR (1) | KR870000305A (de) |
| AT (1) | ATE56020T1 (de) |
| AU (1) | AU590283B2 (de) |
| CA (1) | CA1273450A (de) |
| DE (1) | DE3673709D1 (de) |
| DK (1) | DK290386A (de) |
| FI (1) | FI862422A (de) |
| GR (1) | GR861578B (de) |
| HU (1) | HUT41741A (de) |
| IL (1) | IL79138A (de) |
| IT (1) | IT1222367B (de) |
| NO (1) | NO166409C (de) |
| NZ (1) | NZ216552A (de) |
| PH (2) | PH23229A (de) |
| ZA (1) | ZA864446B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1209644B (it) * | 1985-06-21 | 1989-08-30 | Isf Spa | Composti farmacologicamente attivi. |
| FR2677984B1 (fr) * | 1991-06-21 | 1994-02-25 | Elf Sanofi | Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant. |
| JP2606026B2 (ja) * | 1991-07-09 | 1997-04-30 | コクヨ株式会社 | フォルダー |
| EP1263735B1 (de) * | 2000-01-18 | 2007-07-04 | The Regents of The University of California | Imidazolidinonen-saureadditionssalze als reaktionskatalysatoren |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH470396A (de) * | 1963-08-12 | 1969-03-31 | Hoffmann La Roche | Verfahren zur Herstellung von 4-Imidazolidon-Verbindungen |
| IT1209644B (it) * | 1985-06-21 | 1989-08-30 | Isf Spa | Composti farmacologicamente attivi. |
-
1985
- 1985-06-21 IT IT21236/85A patent/IT1222367B/it active
-
1986
- 1986-06-06 FI FI862422A patent/FI862422A/fi not_active Application Discontinuation
- 1986-06-13 ZA ZA864446A patent/ZA864446B/xx unknown
- 1986-06-16 NZ NZ216552A patent/NZ216552A/xx unknown
- 1986-06-17 IL IL79138A patent/IL79138A/xx unknown
- 1986-06-17 EP EP86304650A patent/EP0207680B1/de not_active Expired - Lifetime
- 1986-06-17 DE DE8686304650T patent/DE3673709D1/de not_active Expired - Lifetime
- 1986-06-17 AT AT86304650T patent/ATE56020T1/de not_active IP Right Cessation
- 1986-06-18 GR GR861578A patent/GR861578B/el unknown
- 1986-06-20 HU HU862610A patent/HUT41741A/hu unknown
- 1986-06-20 US US06/876,946 patent/US4703054A/en not_active Expired - Lifetime
- 1986-06-20 JP JP61144688A patent/JPH0688979B2/ja not_active Expired - Lifetime
- 1986-06-20 PH PH33924A patent/PH23229A/en unknown
- 1986-06-20 NO NO862487A patent/NO166409C/no unknown
- 1986-06-20 KR KR1019860004922A patent/KR870000305A/ko not_active Application Discontinuation
- 1986-06-20 CA CA000512111A patent/CA1273450A/en not_active Expired - Fee Related
- 1986-06-20 DK DK290386A patent/DK290386A/da not_active Application Discontinuation
- 1986-06-20 AU AU58917/86A patent/AU590283B2/en not_active Ceased
-
1987
- 1987-08-20 PH PH35708A patent/PH24336A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US4703054A (en) | 1987-10-27 |
| DK290386A (da) | 1987-02-11 |
| JPS6230763A (ja) | 1987-02-09 |
| HUT41741A (en) | 1987-05-28 |
| EP0207680A2 (de) | 1987-01-07 |
| ZA864446B (en) | 1987-03-25 |
| KR870000305A (ko) | 1987-02-17 |
| IT8521236A0 (it) | 1985-06-21 |
| DE3673709D1 (de) | 1990-10-04 |
| CA1273450A (en) | 1990-08-28 |
| GR861578B (en) | 1986-10-21 |
| AU590283B2 (en) | 1989-11-02 |
| IT1222367B (it) | 1990-09-05 |
| FI862422A (fi) | 1986-12-22 |
| DK290386D0 (da) | 1986-06-20 |
| EP0207680A3 (en) | 1989-01-18 |
| NO166409B (no) | 1991-04-08 |
| NO862487L (no) | 1986-12-22 |
| NZ216552A (en) | 1989-11-28 |
| NO166409C (no) | 1991-07-24 |
| EP0207680B1 (de) | 1990-08-29 |
| IL79138A (en) | 1991-04-15 |
| PH23229A (en) | 1989-06-06 |
| JPH0688979B2 (ja) | 1994-11-09 |
| PH24336A (en) | 1990-06-13 |
| AU5891786A (en) | 1986-12-24 |
| FI862422A0 (fi) | 1986-06-06 |
| NO862487D0 (no) | 1986-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1193256A8 (de) | Pharmazeutisch aktive Benzolsulfonamidderivate als JNK-Proteininhibitoren | |
| ATE56020T1 (de) | Chemische verbindungen. | |
| ATE73821T1 (de) | Pyrrolidonderivate. | |
| ATE60787T1 (de) | Pharmakologisch wirksame verbindungen. | |
| FI873145A (fi) | Nya tetracykliska indolderivat. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |